Clinical Trial Update: TAS-102 and Oxaliplatin for the Treatment of Refractory Stage IV Colon Cancer [Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 2 study evaluating TAS-102 in combination with Oxaliplatin for metastatic colorectal cancer. The trial is currently active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)
• TAS-102 (trifluridine/tipiracil)

Snippet

Sponsor: Rutgers, The State University of New Jersey | Conditions: Metastatic Colorectal Carcinoma, Recurrent Colon Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING